{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:10:15Z","timestamp":1782493815115,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A high incidence of malignant tumors, such as post-transplant lymphoproliferative disorders (PTLD), Kaposi sarcoma, and renal cancer is common in solid organ and bone marrow transplant recipients. However, myeloid sarcoma (MS) after renal transplantation has rarely been reported and the diagnosis is challenging due to its low incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we report a rare case of a 49-year-old man who developed myeloid sarcoma (MS) in the transplanted kidney two years after renal transplantation. Next-generation sequencing (NGS) showed mutations of KRAS and DNMT3A genes in the MS, and no gene mutations in the bone marrow. He presented a normal karyotype of 46, XY. Following treatment with 6 cycles of systemic chemotherapy, the patient was in satisfactory condition with stable serum creatinine (sCr) levels at the 1-year follow-up. In addition, we performed a detailed review with emphasis on the clinical manifestations, and the diagnostic and therapeutic processes of another 7 patients who developed MS following renal transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our report illustrates the clinical utility of comprehensive genomic profiling in benefiting the diagnosis of MS, the selection of therapeutic strategy and the determination of whether MS is donor-derived.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-021-01141-z","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T07:03:29Z","timestamp":1630393409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations"],"prefix":"10.1186","volume":"16","author":[{"given":"Danyang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-1958","authenticated-orcid":false,"given":"Ran","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"issue":"2","key":"1141_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.7314\/APJCP.2012.13.2.575","volume":"13","author":"M Yunus","year":"2012","unstructured":"Yunus M, Aziz T, Mubarak M. Posttransplant malignancies in renal transplant recipients: 22-years experience from a single center in Pakistan. Asian Pac J Cancer Prev. 2012;13(2):575\u20138.","journal-title":"Asian Pac J Cancer Prev."},{"issue":"4","key":"1141_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00007890-200202270-00017","volume":"73","author":"HM Kauffman","year":"2002","unstructured":"Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors1. Transplantation. 2002;73(4):579\u201382.","journal-title":"Transplantation."},{"issue":"5","key":"1141_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","volume":"17","author":"LM Almond","year":"2017","unstructured":"Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid Sarcoma: Presentation, Diagnosis, and Treatment. Clin Lymphoma Myeloma Leuk. 2017;17(5):263\u20137.","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"11","key":"1141_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","volume":"40","author":"K Kawamoto","year":"2016","unstructured":"Kawamoto K, Miyoshi H, Yoshida N, Takizawa J, Sone H, Ohshima K. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients. Am J Surg Pathol. 2016;40(11):1473\u201383.","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"1141_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/10428194.2017.1339879","volume":"59","author":"K Kashofer","year":"2018","unstructured":"Kashofer K, Gornicec M, Lind K, Caraffini V, Schauer S, Beham-Schmid C, et al. Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. Leuk Lymphoma. 2018;59(2):501\u20134.","journal-title":"Leuk Lymphoma."},{"issue":"17","key":"1141_CR6","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1182\/blood-2012-05-378596","volume":"120","author":"AF Ward","year":"2012","unstructured":"Ward AF, Braun BS, Shannon KM. Targeting oncogenic Ras signaling in hematologic malignancies. Blood. 2012;120(17):3397\u2013406.","journal-title":"Blood."},{"issue":"5","key":"1141_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41408-018-0083-6","volume":"8","author":"M Choi","year":"2018","unstructured":"Choi M, Jeon YK, Sun CH, Yun HS, Hong J, Shin DY, et al. RTK-RAS pathway mutation is enriched in myeloid sarcoma. Blood Cancer J. 2018;8(5):43.","journal-title":"Blood Cancer J."},{"issue":"4","key":"1141_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000497210","volume":"42","author":"M Magdy","year":"2019","unstructured":"Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Myeloid Sarcoma. Oncol Res Treat. 2019;42(4):224\u20139.","journal-title":"Oncol Res Treat."},{"issue":"7","key":"1141_CR9","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.transproceed.2014.02.007","volume":"46","author":"M AlGhunaim","year":"2014","unstructured":"AlGhunaim M, AlSuwaida A, Zaidi SN, Kfoury H. First case report of acute myeloid sarcoma post renal transplant. Transplant Proc. 2014;46(7):2411\u20133.","journal-title":"Transplant Proc."},{"key":"1141_CR10","first-page":"821346","volume":"2015","author":"A Palanisamy","year":"2015","unstructured":"Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, et al. Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Case Rep Nephrol. 2015;2015:821346.","journal-title":"Case Rep Nephrol."},{"issue":"7","key":"1141_CR11","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.transproceed.2015.06.005","volume":"47","author":"J Shen","year":"2015","unstructured":"Shen J, Du X, Diao X, Zhao L, Wang W, Yu Y, et al. Myeloid Sarcoma Presenting With Multiple Skin and Subcutaneous Mass Without Leukemic Manifestations After Renal Transplantation. Transplant Proc. 2015;47(7):2227\u201332.","journal-title":"Transplant Proc."},{"issue":"1","key":"1141_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12882-018-0838-0","volume":"19","author":"L Ying","year":"2018","unstructured":"Ying L, Tian L, Xie Y, Wang Q, Che X, Yan J, et al. A case of ureteral myeloid sarcoma post-renal transplantation. BMC Nephrol. 2018;19(1):46.","journal-title":"BMC Nephrol."},{"key":"1141_CR13","doi-asserted-by":"crossref","unstructured":"Wong RL, Ketcham M, Irwin T, Akilesh S. Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney. Leukemia. 2020;34(10):2776\u20139.","DOI":"10.1038\/s41375-020-0903-0"},{"issue":"12","key":"1141_CR14","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.3109\/10428194.2012.695360","volume":"53","author":"T Williams","year":"2012","unstructured":"Williams T, Aljitawi OS, Moussa R, McHugh S, Dusing R, Abraha J, et al. First case of donor transmitted non-leukemic promyelocytic sarcoma. Leuk Lymphoma. 2012;53(12):2530\u20134.","journal-title":"Leuk Lymphoma."},{"issue":"5","key":"1141_CR15","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-09-1220","volume":"19","author":"SC Quinlan","year":"2010","unstructured":"Quinlan SC, Morton LM, Pfeiffer RM, Anderson LA, Landgren O, Warren JL, et al. Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1229\u201337.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"2","key":"1141_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1182\/blood-2013-04-497875","volume":"122","author":"S Girsberger","year":"2013","unstructured":"Girsberger S, Wehmeier C, Amico P, Dirnhofer S, Marti E, Halter J, et al. Donor-derived acute myeloid leukemia in a kidney transplant recipient. Blood. 2013;122(2):298\u2013300.","journal-title":"Blood."}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01141-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01141-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01141-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T07:05:54Z","timestamp":1630393554000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01141-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01141-z","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"assertion":[{"value":"11 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication. All authors are in agreement for the publication of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}